Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 March 2024 | Story Athembele Yangaphi | Photo SUPPLIED
Shoe Box
Supporting Student Success: UFS initiatives like the Santa Shoebox Project and the No Student Hungry Programme combat food insecurity, providing essential resources for students and fostering academic growth and community impact.

The University of the Free State's (UFS’s) Division of Student Affairs recently received a donation of food parcels for needy students from the Gift of the Givers Foundation. The donation forms part of the work done by the Division, the Food Environment Office and Kovsie ACT to positively impact students.

Jady Carelse, Assistant Officer in the Food Environment Office, accepted Gift of the Givers’ 250 food parcels at the UFS’s Bloemfontein Campus. “Starting a year can be very overwhelming for most students, especially first-time-entering students, as they are still trying to adapt to the change of environment,” Carelse said. “The Food Environment Office strives to ensure that food insecurity is not part of their struggle.”

Since its inception in 2011, the No Student Hungry Programme (NSH), a first in a higher education institution, continues to support students with food packages, especially those not funded by the National Student Financial Aid Scheme.

“The NSH has impacted the lives of many students through the food parcel initiative. We have received testimonies from our previous and current beneficiaries on how the initiative has impacted their lives in pursuing their academics,” added Carelse.

The NSH programme's food parcel initiative and the Santa Shoebox Project by the Division of Student Affairs are vital in supporting students, especially those from disadvantaged backgrounds, in their academic pursuits.

The Santa Shoebox Project, which ran from 1 November 2023 to 1 March 2024, is one of many other initiatives that the Kovsie ACT office is highly passionate about. A-Step Assistant, Likhona Dladla, managing Kovsie ACT Community Service Portfolio, said, “We strive to be a helping hand to students by providing them with essential items such as toiletries, sanitary pads, stationery, and clothes to make their academic journey bearable.”

For the 2023/2024 Santa Shoebox Project, UFS residences donated 246 shoeboxes containing donations of toiletries for students in need. Residence Committee members responsible for community portfolios collected the donations from residence students and delivered the items in shoeboxes to the Kovsie ACT office.

“We believe that the donations we have received are of a high standard for the remaining projects and initiatives,” Dladla said.

Kovsie ACT welcomes donations from individuals beyond the university's residential community. Donations can be made directly at the Kovsie ACT office on the Bloemfontein Campus, and the team is ready to assist and accept contributions. Non-residents can also contribute through the annual Big Give donation drive, which encourages donations of non-perishable food items, sanitary pads, and clothing. Look for Big Give donation boxes around campus, gates, and key locations. Stay updated on donation drives and campaigns via campus posters and social media. Please click here to make a monetary donation to support the ‘Back a Buddy’ campaign.  

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept